Archives
-
One-step TUNEL Cy3 Apoptosis Detection Kit Guide
2026-08-28
This scenario-based guide explains how the One-step TUNEL Cy3 Apoptosis Detection Kit, SKU K1134, can address common problems in DNA fragmentation and apoptosis workflows. It covers assay principles, sample compatibility, controls, interpretation, and practical vendor-selection criteria for research teams.
-
The 4Q Principle for Stable mRNA Delivery
2026-08-27
The 2024 Chemistry of Materials study introduces a 4Q framework that treats mRNA delivery as a sequence of stability, diffusion, cellular entry, and intracellular release steps. Its disulfide-containing polycatechol, PBD, produced room-temperature-stable polyplexes and substantially higher in vivo fluorescence than a jetPEI benchmark, offering a practical design logic for nonviral mRNA vectors.
-
SPRTN Ubiquitin Binding and DPC Proteolysis
2026-08-27
A 2024 bioRxiv preprint identifies a ubiquitin-binding interface within the catalytic SprT region of SPRTN and links ubiquitin-chain recognition to selective DNA-protein crosslink proteolysis. The work provides a mechanistic explanation for how SPRTN distinguishes polyubiquitinated DPCs from unmodified lesions and activates proteolysis approximately 67-fold more strongly.
-
DPPH Radical: Mechanism, Assay & Evidence
2026-08-26
DPPH, or 2,2-Diphenyl-1-Picrylhydrazyl, is a nitrogen-centered stable radical used for rapid in vitro antioxidant screening. Its violet-to-yellow reduction signal supports compound and extract ranking, but it does not by itself establish cellular antioxidant efficacy or a therapeutic mechanism.
-
Formononetin Protects Against Oxaliplatin Neurotoxicity
2026-08-26
The reference study identifies formononetin as a candidate neuroprotectant that reduces oxaliplatin-induced oxidative stress and neuronal apoptosis through the Nrf2/HO-1 pathway. Its most important translational finding is that protection of dorsal root ganglion neurons was achieved without reducing oxaliplatin or paclitaxel anticancer activity in the tested cancer cell models.
-
Jasplakinolide: Actin Polymerization Inducer
2026-08-25
Jasplakinolide is a membrane-permeable actin polymerization inducer that also stabilizes pre-existing F-actin. Its competitive binding to actin, ion-dependent behavior, and DMSO-compatible handling make it a useful actin cytoskeleton research tool when paired with appropriate controls.
-
131I-MIBG–PARP Synergy in PPGL Models
2026-08-25
Song et al. investigated whether the radionuclide therapy 131I-MIBG could work synergistically with the PARP inhibitor fluzoparib in norepinephrine transporter-overexpressing pheochromocytoma and paraganglioma models. The combination increased G2/M arrest and apoptosis, while SDHB suppression selectively heightened sensitivity to fluzoparib rather than changing the response to 131I-MIBG.
-
Estradiol Benzoate: From Receptor Signal to Translation
2026-08-24
A mechanistic and translational guide to using Estradiol Benzoate as an estrogen receptor alpha agonist, with practical assay design, quality considerations, and lessons from structure-based NSP15 inhibitor screening.
-
REV1–DHX36 Control of G-Quadruplex Replication
2026-08-24
A 2026 Nucleic Acids Research study identifies a direct REV1–DHX36 interaction that coordinates G-quadruplex unwinding, replication-fork progression, and suppression of single-stranded DNA gaps. The findings establish a two-tier mechanism for G4 tolerance and clarify how loss of REV1 reshapes replication, mutagenesis, and ATM/ATR DNA damage response signaling.
-
Dual Luciferase Reporter Gene System Guide
2026-08-23
The Dual Luciferase Reporter Gene System pairs firefly and Renilla signals to distinguish true promoter effects from sample-to-sample variation. This guide translates the system into practical promoter-mapping, transcription-factor, and high-throughput workflows, with troubleshooting informed by a recent tomato aluminium-tolerance study.
-
HDAC Inhibition Reverses EBV-Driven NPC Dedifferentiation
2026-08-22
The reference study identifies an epigenetic mechanism by which EBV latent membrane protein 1 drives dedifferentiation and stem-like plasticity in nasopharyngeal carcinoma. It shows that HDAC inhibition can restore CEBPA expression and partially reverse this state in cellular and mouse xenograft models, providing a mechanistic rationale for differentiation-oriented treatment of a solid tumor.
-
Elobixibat Hydrate: Mechanism-to-Assay Guide
2026-08-22
Elobixibat hydrate is an ileal bile acid transporter inhibitor whose effects are best understood through a layered assay strategy rather than a single endpoint. This guide connects IBAT pharmacology with orthogonal transporter, signaling, tissue, and translational readouts while extracting practical assay lessons from a mechanistic receptor study.
-
EdU Flow Cytometry Assay Kits (Cy5) in CRC
2026-08-21
EdU Flow Cytometry Assay Kits (Cy5) provide a practical way to quantify S-phase DNA synthesis while preserving cells for cell-cycle and immune-marker analysis. This article shows how to apply the assay to colorectal cancer models, diet-immunotherapy studies, pharmacodynamic testing, and troubleshooting-heavy flow cytometry workflows.
-
Flumequine: DNA Topoisomerase II Inhibitor
2026-08-20
Flumequine is a synthetic small-molecule DNA topoisomerase II inhibitor used for enzyme inhibition, DNA replication research, and drug-response studies. The B2292 material is reported at greater than 98% purity, with an approximate vendor-reported IC50 of 15 μM under the listed assay conditions.
-
Geneticin: G418 Sulfate Selection Workflows
2026-08-20
Geneticin, G418 Sulfate enables reproducible enrichment of neomycin-resistant cells while supporting carefully controlled antiviral experiments. This guide connects practical selection workflows with the macrophage EV–miR-660 breast cancer model, highlighting assay design, optimization, and cross-domain limitations.